Background
Autism Spectrum Disorder (ASD) is a set of highly heterogeneous neurodevelopmental diseases whose genetic etiology is not completely understood. Several investigations have relied on transcriptome analysis from peripheral tissues to dissect ASD into homogenous molecular phenotypes. Recently, alterations of gene expression from post-mortem brain tissues have identified sets of genes with altered expression, mapping on pathways known to be involved in ASD etiology. In addition to protein-coding transcripts, the human transcriptome is composed by a large set of non-coding RNAs and transposable elements (TEs). Advancements in sequencing technologies have proved that TEs can be transcribed in a regulated fashion, and their dysregulation have a role in neural diseases.
Methods
We exploited published datasets comprising RNA-seq data from 1) post-mortem brain of ASD subjects, 2) in vitro cell cultures where ten different ASD-relevant genes were knocked out and 3) blood of discordant siblings. We measured the expression levels of evolutionarily young full-length transposable L1 elements and characterized the genomic location of deregulated L1s assessing their potential impact on the transcription of ASD-relevant genes.
Results
We detected a strong upregulation of intronic full length L1s exclusively in a subset of samples where the number of deregulated genes correlates with L1 upregulation. In brain tissue, specific upregulated L1s overlap ASD-relevant downregulated genes, suggesting the existence of a negative effect of L1 transcription on host transcripts for a subset of ASD genes.
Limitations
Our analyses are limited by the low number of samples and by the lack of replicates among post-mortem brain samples. Measuring the transcription of locus-specific TEs is complicated by the repetitive nature of their sequence, which reduces the accuracy in mapping sequencing reads to the correct genomic locus.
Conclusions
We observed L1s upregulation in a subset of ASD samples. In these cases, L1 upregulation might directly impair the expression of ASD-relevant genes by a mechanism not yet understood. L1s upregulation in autism appears to be limited to a subset of subjects probably harbouring mutations in genes related to DNA/chromatin modification.